Literature DB >> 28431364

The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research.

Mark P Jensen1, Andreas Brunklaus2, Liam Dorris2, Sameer M Zuberi2, Kelly G Knupp3, Bradley S Galer4, Arnold R Gammaitoni4.   

Abstract

We reviewed the current literature with respect to the humanistic and financial burdens of Dravet Syndrome (DS) on the caregivers of children with DS, in order to (1) identify key unanswered questions or gaps in knowledge that need to be addressed and then, based on these knowledge gaps, (2) propose a research agenda for the scientific community to address in the coming decade. The findings support the conclusion that caring for a child with DS is associated with significant humanistic burden and direct costs. However, due in part to the paucity of studies, as well as the lack of measures of specific burden domains, there remains much that is not known regarding the burden of caregiving for children with DS. To address the significant knowledge gaps in this area, research is needed that will: (1) identify the specific domains of caregivers' lives that are impacted by caring for a child with DS; (2) identify or, if needed, develop measures of caregiving impact in this area; (3) identify the factors that influence DS caregiving burden; (4) develop and evaluate the efficacy of treatments for reducing the negative impact of DS and its comorbidities on DS caregivers; (5) quantify the direct medical costs associated with DS and DS comorbidities and identify the factors that influence these costs; and (6) quantify and fully explore the indirect costs of DS. Research that addresses these goals will provide the empirical foundation needed for improving the quality of life of children with DS and their families.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Caregiver burden; Costs; Dravet syndrome; Severe myoclonic epilepsy in infancy

Mesh:

Year:  2017        PMID: 28431364     DOI: 10.1016/j.yebeh.2017.02.003

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  9 in total

Review 1.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

Review 2.  The Promising Epigenetic Regulators for Refractory Epilepsy: An Adventurous Road Ahead.

Authors:  Vemparthan Suvekbala; Haribaskar Ramachandran; Alaguraj Veluchamy; Mariano A Bruno Mascarenhas; Tharmarajan Ramprasath; M K C Nair; Venkata Naga Srikanth Garikipati; Rohit Gundamaraju; Ramasamy Subbiah
Journal:  Neuromolecular Med       Date:  2022-09-24       Impact factor: 4.103

Review 3.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

4.  Coping with Wolf-Hirschhorn syndrome: quality of life and psychosocial features of family carers.

Authors:  Sarah Berrocoso; Imanol Amayra; Esther Lázaro; Oscar Martínez; Juan Francisco López-Paz; Maitane García; Manuel Pérez; Mohammad Al-Rashaida; Alicia Aurora Rodríguez; Paula Maria Luna; Paula Pérez-Núñez; Raquel Blanco; Julián Nevado
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

Review 5.  Cost-of-illness studies in rare diseases: a scoping review.

Authors:  Lidia García-Pérez; Renata Linertová; Cristina Valcárcel-Nazco; Manuel Posada; Inigo Gorostiza; Pedro Serrano-Aguilar
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

6.  The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study.

Authors:  Ángel Aledo-Serrano; Ana Mingorance; Vicente Villanueva; Juan José García-Peñas; Antonio Gil-Nagel; Susana Boronat; JoséÁngel Aibar; Silvia Cámara; María José Yániz; Luis Miguel Aras; Bárbara Blanco; Rocío Sánchez-Carpintero
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

7.  Financial Burden in Families of Children with West Syndrome.

Authors:  Dhvani Raithatha; Jitendra Kumar Sahu; Singanamalla Bhanudeep; Lokesh Saini; Shankar Prinja; Bhavneet Bharti; Priyanka Madaan; Saroj Kumar Rana; Sandeep Negi
Journal:  Indian J Pediatr       Date:  2021-05-26       Impact factor: 1.967

8.  Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.

Authors:  Wyman W Lai; Bradley S Galer; Pierre C Wong; Gail Farfel; Milka Pringsheim; Martin G Keane; Anupam Agarwal
Journal:  Epilepsia       Date:  2020-08-18       Impact factor: 5.864

Review 9.  Rare, epilepsy-related disorder including intellectual disability - A scoping review of caregivers' identified information needs.

Authors:  Merete Kristin Tschamper; Silje Systad
Journal:  J Intellect Disabil       Date:  2021-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.